Michael W. Starbuck

Spanish Oncology Genitourinary Group — Spain

Medicine · Health Sciences

23h-index6.4kcitations48works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and treatments(22), Prostate Cancer Treatment and Research(18), Fibroblast Growth Factor Research(9), Cancer, Lipids, and Metabolism(9), Bone Metabolism and Diseases(8)

Publications48 total

Data from Inhibition of Prostate Cancer Osteoblastic Progression with VEGF<sub>121</sub>/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature
2023Open Access
Data from Inhibition of Prostate Cancer Osteoblastic Progression with VEGF<sub>121</sub>/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature
2023Open Access
Supplementary Figure S1 from Inhibition of Prostate Cancer Osteoblastic Progression with VEGF<sub>121</sub>/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature
2023Open Access
Data from Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells
2023Open Access
Supplementary Table 1 from Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells
2023Open Access
Data from Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells
2023Open Access
Supplementary Table 1 from Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells
2023Open Access
Supplementary Figure S1 from Inhibition of Prostate Cancer Osteoblastic Progression with VEGF<sub>121</sub>/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature
2023Open Access
Treatment outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) with sarcomatoid and/or rhabdoid (S/R) features after progressive disease (PD) on immune checkpoint therapy (ICT): The MD Anderson Cancer Center experience.
Journal of Clinical Oncology·2022· 1 cited
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies
Cancers·2021· 28 citedOpen Access
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
European Urology Oncology·2021· 26 citedOpen Access
High-intensity exercise is a risk factor for renal medullary carcinoma in individuals with sickle cell trait
2021Open Access
Adiposity and response to androgen signaling inhibition (ASI) in men with metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2021
669P Body composition and clinical outcomes in men with metastatic castration-resistant prostate cancer (mCRPC)
Annals of Oncology·2020
Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis
Antioxidants and Redox Signaling·2019· 21 citedOpen Access
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease
Science Translational Medicine·2019· 107 citedOpen Access
Abstract B050: The role of activated beta-catenin/Wnt signaling in the progression of castration resistance of prostate cancer in bone
Cancer Research·2018
Abstract A026: Expression of fibroblast growth factor receptor 1 isoforms and activation of different pathways in prostate cancer progression
Cancer Research·2018
Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone
Science Translational Medicine·2018· 52 cited
Abstract 2870: A specific pan-FGFR inhibitor has antitumor activity against prostate cancer patient derived xenografts, PDX, expressing high FGFR1
Cancer Research·2018
page 1 of 3Next →

Frequent Co-authors

Nora M. Navone(26), Xinhai Wan(17), Eleni Efstathiou(11), Elba S. Vázquez(11), Patricia Troncoso(9), Gérard Karsenty(8), Zhigang Li(8), Jun Yang(7), Vikas Kundra(7), Christopher J. Logothetis(7), Sankar N. Maity(7), Khalid A. Mohamedali(7), Michael G. Rosenblum(7), Sehoon Kim(6), Jun Yang(6), Amado J. Zurita(5), Paul G. Corn(5), Vassiliki Tzelepi(5), Lixia Diao(5), Devaki Shilpa Surasi(5)